JP2009539998A5 - - Google Patents

Download PDF

Info

Publication number
JP2009539998A5
JP2009539998A5 JP2009515487A JP2009515487A JP2009539998A5 JP 2009539998 A5 JP2009539998 A5 JP 2009539998A5 JP 2009515487 A JP2009515487 A JP 2009515487A JP 2009515487 A JP2009515487 A JP 2009515487A JP 2009539998 A5 JP2009539998 A5 JP 2009539998A5
Authority
JP
Japan
Prior art keywords
indol
nicotinonitrile
methyl
amino
ylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009515487A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009539998A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/013954 external-priority patent/WO2007146376A2/en
Publication of JP2009539998A publication Critical patent/JP2009539998A/ja
Publication of JP2009539998A5 publication Critical patent/JP2009539998A5/ja
Withdrawn legal-status Critical Current

Links

JP2009515487A 2006-06-13 2007-06-13 プロテインキナーゼ阻害剤としての置換3−シアノピリジン Withdrawn JP2009539998A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81306006P 2006-06-13 2006-06-13
PCT/US2007/013954 WO2007146376A2 (en) 2006-06-13 2007-06-13 Substituted 3-cyanopyridines as protein kinase inhibitors

Publications (2)

Publication Number Publication Date
JP2009539998A JP2009539998A (ja) 2009-11-19
JP2009539998A5 true JP2009539998A5 (cg-RX-API-DMAC7.html) 2010-07-29

Family

ID=38738795

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009515487A Withdrawn JP2009539998A (ja) 2006-06-13 2007-06-13 プロテインキナーゼ阻害剤としての置換3−シアノピリジン

Country Status (18)

Country Link
EP (1) EP2029543B1 (cg-RX-API-DMAC7.html)
JP (1) JP2009539998A (cg-RX-API-DMAC7.html)
KR (1) KR20090018612A (cg-RX-API-DMAC7.html)
CN (1) CN101466678B (cg-RX-API-DMAC7.html)
AR (1) AR061368A1 (cg-RX-API-DMAC7.html)
AU (1) AU2007258237A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0712737A2 (cg-RX-API-DMAC7.html)
CA (1) CA2654515C (cg-RX-API-DMAC7.html)
CL (1) CL2007001737A1 (cg-RX-API-DMAC7.html)
ES (1) ES2558706T3 (cg-RX-API-DMAC7.html)
IL (1) IL194625A0 (cg-RX-API-DMAC7.html)
MX (1) MX2008015802A (cg-RX-API-DMAC7.html)
NO (1) NO20084739L (cg-RX-API-DMAC7.html)
PE (1) PE20080336A1 (cg-RX-API-DMAC7.html)
RU (1) RU2008139079A (cg-RX-API-DMAC7.html)
TW (1) TW200815407A (cg-RX-API-DMAC7.html)
WO (1) WO2007146376A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200810573B (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2027093A2 (en) * 2006-06-13 2009-02-25 Wyeth Substituted cyanopyridines as protein kinase inhibitors
BRPI0918846A2 (pt) * 2008-09-02 2019-09-24 Novartis Ag inibidores de cinase heterocíclica
CN113735785B (zh) * 2020-05-28 2023-10-13 南京桦冠生物技术有限公司 3,6-二氯吡嗪-2-甲腈的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE255575T1 (de) * 1998-09-29 2003-12-15 Wyeth Corp Substituierte 3-cyanochinoline als protein tyrosine kinase inhibitoren
AR037438A1 (es) * 2001-11-27 2004-11-10 Wyeth Corp 3-cianoquinolinas como inhibidores de egf-r y her2 quinasas, un proceso para su preparacion, composiciones farmaceuticas y el uso de dichos compuestos para la fabricacion de medicamentos
MXPA05006367A (es) * 2002-12-12 2005-08-29 Pharmacia Corp Metodo de uso de compuestos de aminocianopiridina como inhibidores de cinasa-2 de proteina activada de cinasa de proteina activada por mitogeno.
EP1888529A2 (en) * 2005-05-18 2008-02-20 Wyeth 3-cyanoquinoline inhibitors of tpl2 kinase and methods of making and using the same

Similar Documents

Publication Publication Date Title
JP2019525941A5 (cg-RX-API-DMAC7.html)
JP6109974B2 (ja) チロシンキナーゼ調節剤としての化合物
CN101715442B (zh) 杂环天冬氨酰蛋白酶抑制剂
RU2672916C2 (ru) Производные пиримидин-2,4-диамина для лечения рака
JP2011518836A5 (cg-RX-API-DMAC7.html)
JP2005538953A5 (cg-RX-API-DMAC7.html)
JP2010513444A5 (cg-RX-API-DMAC7.html)
JP2002516909A5 (cg-RX-API-DMAC7.html)
RU2205827C2 (ru) Производное ацилпиперазинилпиримидина, способы его получения, фармацевтическая композиция
JP2011517458A5 (cg-RX-API-DMAC7.html)
JP2006513261A5 (cg-RX-API-DMAC7.html)
JP2007523905A5 (cg-RX-API-DMAC7.html)
RU2017139727A (ru) Гетероциклические ингибиторы erk1 и erk2 и их применение для лечения злокачественного новообразования
JP2005530748A (ja) ヒストンデアセチラーゼ阻害剤
WO2002010137A2 (en) Indazole derivatives as jnk inhibitors
AU2001279089A1 (en) Indazole derivatives as JNK inhibitors
SK1812002A3 (en) 3(5)-Amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
WO2004094388A2 (en) Indazole derivatives as jnk inhibitors
MXPA04009541A (es) Benzazoles sustituidos y uso de los mismos como inhibidores de cinasa raf.
JP2013517273A5 (cg-RX-API-DMAC7.html)
JP2009203238A (ja) イミダゾール誘導体
JP2008500336A5 (cg-RX-API-DMAC7.html)
JP2012526803A5 (cg-RX-API-DMAC7.html)
RU2006129492A (ru) Производные индола и их применение в качестве ингибиторов киназ, в частности, ингибиторов ikk2
WO2012149528A1 (en) Inhibitors of inducible form of 6-phosphofructose-2-kinase